1. British pharmacopoeia (2009) London: Medicines and Healthcare products Regulatory Agency, vol. 1
2. Laccourreye O, Werner A, Giroud J, Couloigner V, Bonfils P (2015) Benefits, limits and danger of ephedrine and pseudoephedrine as nasal decongestants.Eur Ann Otorhinolaryngol Head Neck Dis 132: 28–31
3. Goodman-Hillman A, Rall T, Nier A, Taylor P (1996) The Pharmacologycal Basis of Therapeutics. McGraw-Hill, New York, pp 235–238
4. Mirsonbol SZ, Issazadeh K, Majid MR, Pahlaviani K, Momeni N (2014) Antimicrobial efficacy of the methylparaben and benzoate sodium against selected standard microorganisms, clinical and environmental isolates in vitro. Indian J Fund Appl Life Sci 4:263–367
5. The United States Pharmacopoia and National Formulary (2007) The official Compendia of Standards, Asian Edition, USP 30-NF 25 The United States Pharmacopeial Conversion Inc., Rockvill,MD